Intended for healthcare professionals


Ginkgo biloba and acetazolamide for acute mountain sickness: Exclusion of high risk, low status groups perpetuates discrimination and inequalities

BMJ 2004; 329 doi: (Published 15 July 2004) Cite this as: BMJ 2004;329:171
  1. Jean Adams (, research fellow
  1. School of Population and Health Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH

    EDITOR—Gertsch et al report the results of a randomised controlled trial of ginkgo biloba and acetazolamide for acute mountain sickness in trekkers in the Everest region of Nepal.1 However, it is …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription